HealthcareDr. Reddy's launches generic Angiomax in U.S.Jun. 06, 2017 7:25 AM ETDr. Reddy's Laboratories Limited (RDY) StockBy: Douglas W. House, SA News Editor Dr. Reddy's Laboratories (NYSE:RDY) commences the U.S. commercial launch of its generic version of The Medicines Company's (MDCO) anticoagulant Angiomax (bivalirudin). According to IMS Health, the U.S. market is ~$200M. Recommended For YouMore Trending NewsSee More »About RDY StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgRDY--Dr. Reddy's Laboratories LimitedTrending AnalysisTrending News